Publication|Articles|October 15, 2026

Pharmacy Practice in Focus: Oncology

  • October 2026
  • Volume 8
  • Issue 7

Peptide Vaccines: The Next Frontier in Precision Cancer Treatment

Fact checked by: Ron Panarotti

Peptide cancer vaccines target neoantigens to boost T cells, with promising melanoma and pancreatic trials hinting at a new era in immunotherapy.

Vaccination is a simple, safe, and effective process that teaches the immune system to generate protective responses against specific diseases through active immunization.1 It is estimated that vaccines have averted approximately 154 million deaths, with 146 million specifically in children younger than 5 years.2 Although the practice of immunizing remains a cornerstone of public health and disease prevention, vaccination focus is expanding to consider the same principle of active immunization for established diseases such as cancer.3

Related to this article